Afficher la notice abrégée

dc.contributor.authorLópez Gómez, Juan José 
dc.contributor.authorDelgado García, Esther
dc.contributor.authorCoto García, Cristina
dc.contributor.authorTorres Torres, Beatriz 
dc.contributor.authorGómez Hoyos, Emilia 
dc.contributor.authorSerrano Valles, Cristina
dc.contributor.authorCastro Lozano, María Ángeles 
dc.contributor.authorArenillas Lara, Juan Francisco 
dc.contributor.authorLuis Román, Daniel Antonio de 
dc.date.accessioned2022-10-18T09:22:13Z
dc.date.available2022-10-18T09:22:13Z
dc.date.issued2019
dc.identifier.citationNutrients, 2019, vol. 11, n. 5, 996es
dc.identifier.issn2072-6643es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/55988
dc.descriptionProducción Científicaes
dc.description.abstractObjectives: To evaluate in patients admitted for stroke: (1) The frequency of hyperglycaemia associated with enteral nutrition (EN). (2) The risk of morbidity and mortality associated with the development of this type of hyperglycaemia. Methods: A longitudinal observational study was conducted in 115 non-diabetic patients admitted for stroke with EN. Age, functional capacity (Rankin scale), and blood plasma glucose (BPG) were recorded. Hyperglycaemia was considered as: a value higher than 126 mg/dL before the EN and/or a value higher than 150 mg/dL after a week of enteral nutrition. According to this, three groups were differentiated: HyperES: Those who had hyperglycemia before the beginning of the EN (33% patients); NoHyper: those who did not have hyperglycemia before or after (47.8% patients); and HyperEN: Those who did not have hyperglycemia before but suffered it after the beginning of the EN (19.1% patients). Results: The age was 72.72 (15.32) years. A higher rate of mortality was observed in the HyperEN group 45.50%, than HyperES 15.80% or NoHyper: 10.90%). A lower recovery of the oral feeding was observed in those patients of the HyperEN group 27.30%, than HyperES: 42.10% or NoHyper: 61.80%). In the multivariate analysis adjusting for age, sex, and Rankin scale the development of hyperglycemia in those who did not have it at the beginning (HyperEN) was an independent risk factor for non-recovery of the oral feeding (OR: 4.21 (1.20–14.79), p = 0.02); and mortality adjusted for age, sex and Rankin scale (OR: 6.83 (1.76–26.47), p < 0.01). Conclusions: In non-diabetic patients admitted for stroke with EN, the development of hyperglycaemia in relation to enteral nutrition supposes an independent risk factor for mortality and for the non-recovery of the oral feeding.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherElsevieres
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.classificationHyperglycaemiaes
dc.subject.classificationHiperglucemiaes
dc.subject.classificationEnteral nutritiones
dc.subject.classificationNutrición enterales
dc.subject.classificationDysphagiaes
dc.subject.classificationDisfagiaes
dc.titleInfluence of hyperglycemia associated with enteral nutrition on mortality in patients with strokees
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2019 The Authorses
dc.identifier.doi10.3390/nu11050996es
dc.relation.publisherversionhttps://www.mdpi.com/2072-6643/11/5/996es
dc.peerreviewedSIes
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée